Effect of Nursing Interventions on Pain and Salivary Cortisol Levels During Heel Stick in Preterm Newborns

October 2, 2024 updated by: Zeynem YILDIRIM BALKAN, Namik Kemal University

The Effect of Giving a Pacifier Dipped in Breast Milk, Heel Warming, and Applying Both Together on Pain and Salivary Cortisol Levels During Heel Stick in Preterm Newborns: Randomized Controlled Study.

Babies born before the thirty-seventh gestational week are called preterm or premature. Most preterm newborns require Neonatal Intensive Care Unit (NICU) care depending on their gestational age and clinical condition. Although many painful invasive procedures are usually performed on newborns in the NICU, the most common procedure is heel prick. Heel prick is a painful and stressful procedure for the newborn. Neonates do not respond to pain verbally; they respond physiologically, behaviorally and hormonally. Physiologic responses of preterm infants to pain include increased heart and respiratory rate, increased blood pressure and intracranial pressure, decreased oxygenation, and sweating of palms. Among the hormonal symptoms caused by stress in newborns, the most commonly used biochemical method is the measurement of cortisol level. It is reported that there is a significant correlation between salivary and plasma cortisol levels and salivary cortisol level reflects plasma cortisol level. This method is particularly preferred because saliva sampling is much less stressful.

Study Overview

Detailed Description

Health professionals should be able to evaluate pain, reduce or eliminate pain in pain management of neonates in interventional applications. Pharmacologic and nonpharmacologic methods are used in pain management. When these methods are applied together, their effectiveness increases in pain related to invasive interventions. Pharmacologically, opioid analgesics, sedatives and local anesthetics are used. Nonpharmacologic methods include breastfeeding, pacifier, oral sucrose, music, warm application, massage, therapeutic touch and positioning such as nesting, fetal positioning, swaddling, kangaroo care, rocking and holding.

In many studies, nonpharmacologic interventions have been applied and compared to reduce pain during heel prick in preterm newborns. In the routine of the clinic, heel prick blood collection from preterm newborns is performed by hugging the mother in her lap. The swaddling procedure for preterm newborns in the control group is recommended by the American Academy of Pediatrics. The swaddling method supports flexion and lateral posture, which is the developmental position of the newborn. With this position, the newborn comes to its position in the uterus, which is familiar to it, ensuring its physiological stability and improving its capacity. In a systematic review of 3396 participants, preterm newborns were calmed and immediately stabilized by kangaroo care, non-nutritive sucking and swaddling methods. Since these methods reduce pain and stress in preterm newborns, they are also reported to be included in "Individualized Supportive Developmental Care" practices.

Many studies have shown that giving pacifiers to newborns is effective in reducing pain. In addition, oral administration of breast milk alone, without breastfeeding, has been found to reduce pain during heel prick, nasopharyngeal aspiration, venipuncture and retinopathy examination in preterms. In the study conducted by Lan et al., breast milk was sniffed to the newborn during heel prick blood collection or tasted by dropping into the newborns mouth with a syringe. As a result, they reported that sniffing and plus tasting breast milk was effective in alleviating pain in newborns.

In the literature, it is emphasized that the pain that occurs during heel blood collection is closely related to the squeezing of the heel to collect blood, not during the needle insertion into the heel, and it is thought that keeping the newborn in an upright position during heel blood collection may facilitate blood flow through gravity and reduce the amount of squeezing required to obtain the sample. However, there are studies showing that heel warming is effective in reducing pain in newborns. It has been stated that with warm application to the heel -with the effect of vasodilation- fewer needling is performed in the heel, the amount of blood required for the procedure increases and the procedure is completed in a shorter time. It is predicted that the heel of the newborn will be squeezed less thanks to the warm application.

However, there is a very limited number of studies evaluating the effectiveness of different nonpharmacologic interventions during heel prick blood collection and measuring the stress marker cortisol. In addition, no study was found to investigate the effectiveness of other interventions (heel warming and giving a pacifier dipped in breast milk) in combination with wrapping among nonpharmacological interventions.

This study aimed to reduce pain during heel prick blood collection in preterm newborns by swaddling the baby in the mothers lap (control group), swaddling in the mothers lap together with giving a pacifier dipped in breast milk (pacifier with breast milk group), swaddling in the mother;s lap together with local dry heat application (heel heating group), and all interventions combined (swaddling in the mother;s lap together with giving a pacifier dipped in breast milk and heel heating-combined intervention group). In addition, it was planned as a randomized controlled experimental design to determine and compare the effects of these nursing interventions on the newborns physiological parameters, pain, salivary cortisol level, crying and procedure time.

Place and Time to Conduct the Research:

The research will be carried out between November 2024 and August 2025 in the Neonatal Intensive Care Unit of Tekirdag Namik Kemal University Hospital.

Population and Sample of the Study:

The study population will consist of infants who meet the inclusion criteria in the NICU of Tekirdağ Namik Kemal University between 01.11.2024-01.08.2025.

The sample size of the study was determined by power analysis. The study comparing non-nutritive suction, sucrose and combination interventions in heel prick blood collection in newborns with the control group was taken as a basis. According to the PIPP pain assessment scale used in the study, the 1st experimental group had a mean score of 9.3 ± 1.3, the 2nd experimental group 10.1 ± 2, the 3rd group 4.4 ± 1.5, and the control group 13.3 ± 1.6. In this study, it was determined that a total of 88 infants (22 in each group) should be included in the study in the sample number calculation made in the G*Power (3.1.9.2.) program with a 5% alpha margin of error (two-way) and 80% power, predicting that the PIPP score mean difference would have a large effect size (.95 large effect) (the effect size was found to be 2.74).

Randomization:

The sample will be randomly selected from the study population. In the study, randomization of premature newborns will be performed in a computer environment. The newborns to be subjected to heel prick blood collection were placed in groups with a randomized controlled method with 18 babies in each group. In the study, randomization was performed by entering the number of cases through the program whose URL address is http://www.randomizer.org.

Control (swaddling from mothers lap) 76, 41, 70, 15, 43, 38, 63, 2, 28, 55, 30, 35, 86, 61, 57, 84, 80, 74, 3, 24, 83, 71 Experiment 2 (swaddling from mothers lap + pacifier) 18, 79, 23, 19, 48, 47, 2, 61, 10, 73, 35, 74, 87, 38, 32, 5, 11, 12, 49, 80, 44, 55 Experiment 3 (swaddling from mothers lap + heel warming) 25, 17, 50, 7, 64, 35, 45, 11, 48, 82, 73, 23, 32, 54, 49, 74, 79, 3, 68, 56, 24, 81 Experiment 4 (swaddling from mothers lap + pacifier + heel warming) 57, 33, 21, 64, 13, 47, 56, 31, 41, 28, 43, 85, 20, 1, 75, 52, 11, 14, 3, 6, 38, 15

Study Type

Interventional

Enrollment (Estimated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Zeynem YILDIRIM BALKAN, Assist.Prof.
  • Phone Number: we dnt have US +905073190958
  • Email: zyildirim@nku.edu.tr

Study Contact Backup

  • Name: Birsen Mutlu, Assoc.Prof.
  • Phone Number: we dnt have US +905326826862
  • Email: bdonmez@iuc.edu.tr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Mother 18 years of age or older
  • Mother is literate
  • Whether the mother gives birth naturally or by caesarean section
  • Uncomplicated pregnancy and birth history in mother
  • Mother's voluntary participation in the study
  • Preterm babies between 34 0/7-36 6/7 weeks
  • Prematurity at 34 0/7-36 6/7 weeks and weight appropriate for the week (Appropriate Gestational Age- AGA),
  • The baby should be fed at least 1 hour in advance.
  • It has been 1 hour since the last painful intervention on the baby.
  • 6Heel blood should be taken 6 hours after taking analgesic, sedative and anticonvulsant medications.

Exclusion Criteria:

  • The baby has a fever
  • The baby receiving oxygen therapy,
  • The baby receiving antibiotic treatment
  • The baby has a congenital anomaly
  • The baby having the bed side and heater underneath
  • The baby receiving phototherapy,
  • The baby is connected to a mechanical ventilator
  • Babies whose blood was not collected on the first attempt

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: pacifier with breast milk group
swaddling in the mother's lap together with giving a pacifier dipped in breast milk
swaddling in the mother's lap together with giving a pacifier dipped in breast milk
Experimental: heel heating group
swaddling in the mother's lap together with local dry heat application
swaddling in the mother's lap together with local dry heat application
Experimental: combined intervention group
all interventions combined (swaddling in the mother's lap together with giving a pacifier dipped in breast milk and heel heating
swaddling in the mother's lap together with giving a pacifier dipped in breast milk and heel heating
Other: Control
swaddling the baby in the mother's lap
swaddling the baby in the mother's lap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac apex beat (HRV)
Time Frame: Through study completion, an average of 1 year.
HRV will be evaluated before, during and after the heel blood collection. Each baby will be video recorded for 7-10 minutes before, during and after the procedure by the researcher.
Through study completion, an average of 1 year.
Oxygen saturation (SpO2)
Time Frame: Through study completion, an average of 1 year
SpO2 will be evaluated before, during and after the heel blood collection. Each baby will be video recorded for 7-10 minutes before, during and after the procedure by the researcher. SpO2 will be recorded from this video recording.
Through study completion, an average of 1 year
Crying time
Time Frame: Through study completion, an average of 1 year
The baby crying time will be monitored and recorded 5 minutes before the heel prick and 5 minutes during the heel prick
Through study completion, an average of 1 year
Premature Infant Pain Profile Scale (PIPP-R)
Time Frame: Through study completion, an average of 1 year

The PIPP-R scale includes 3 behavioral (frowning, squeezing eyes, nasolabial groove), 2 physiological (heart rate and oxygen saturation) and 2 contextual (behavioral state and gestational age) items. In the scoring of the scale, items related to physiological and behavioral items are scored as 0,1,2,3 in each variable, reflecting the difference between baseline and treatment values. Items related to contextual items are scored as 3,2,1,0 before touching the baby. The babys pain is evaluated on a total score. Accordingly, the maximum score for newborns is 21. If the premature infant pain profile is between 0-6 points, the pain level in the infant is mild, between 7-12 points is moderate, and between 13-21 points is severe pain.

Each baby will be video monitored and recorded for 7-10 minutes before, during and after the procedure. This video recording will be evaluated and recorded according to the Premature Infant Pain Profile Scale.

Through study completion, an average of 1 year
Salivary cortisol level
Time Frame: Through study completion, an average of 1 year

Since cortisol shows circadian rhythm in premature infants, samples will be taken at the same time in the morning. Before taking saliva samples, the newborns mouth will be checked and oral care will be given with SF. Saliva samples will be collected with the Salimetrics Salivary Cortisol Kit by holding it in the cheek and sublingual cavity of the newborn for 1-2 minutes. The samples will be sent to the biochemistry laboratory of the research hospital. The samples will be analyzed for quantitative determination of cortisol by 2 biochemistry experts using standard procedures in the Biochemistry laboratory of TNKU Hospital.

Samples will be taken twice, both during the procedure and 25 minutes after the procedure (the highest cortisol level after pain in newborns is detected between 20-30 minutes after the procedure).

Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Zeynem YILDIRIM BALKAN, Assist.Prof., Namik Kemal University
  • Principal Investigator: Birsen Mutlu, Assoc.Prof., Istanbul University - Cerrahpasa (IUC)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

August 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

September 29, 2024

First Submitted That Met QC Criteria

October 2, 2024

First Posted (Actual)

October 4, 2024

Study Record Updates

Last Update Posted (Actual)

October 4, 2024

Last Update Submitted That Met QC Criteria

October 2, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PreTerm Neonate

Clinical Trials on pacifier with breast milk

Subscribe